BC
ONC

Bayforest Capital’s BeOne Medicines Ltd ONC Stock Holding History

Bayforest Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2K Sell
71
-45
-39% -$13.3K 0.02% 783
2026
Q1 		$34.4K Buy
+116
New +$37.5K 0.04% 649
2025
Q4 		– Sell
-1,630
Closed -$555K – 990
2025
Q3 		$555K Sell
1,630
-518
-24% -$157K 0.26% 113
2025
Q2 		$520K Buy
2,148
+1,019
+90% +$250K 0.23% 166
2025
Q1 		$307K Buy
+1,129
New +$264K 0.13% 289

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bayforest Capital's ONC Position: Q2 2026 in Review

Bayforest Capital reduced its BeOne Medicines Ltd (ONC) stake by 39% in Q2 2026, selling an estimated $13.3K and leaving 71 shares worth $20.2K. The position accounts for 0.02% of the portfolio, ranked #783.

Bayforest Capital first reported a position in ONC in Q1 2025 and has held it in 5 quarters since. The position peaked at $555K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Bayforest Capital held 71 shares of BeOne Medicines Ltd worth $20.2K as of Q2 2026.
  • Bayforest Capital sold 45 BeOne Medicines Ltd shares in Q2 2026, an estimated $13.3K.
  • BeOne Medicines Ltd made up 0.02% of Bayforest Capital's portfolio in Q2 2026, its #783 holding.
  • Bayforest Capital first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 5 quarters since.
  • Bayforest Capital's BeOne Medicines Ltd position peaked at $555K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.